These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 37944239)
21. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. Chen Y; Yu Y J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321 [TBL] [Abstract][Full Text] [Related]
22. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607 [TBL] [Abstract][Full Text] [Related]
23. The Molecular Mechanisms of Neuroinflammation in Alzheimer's Disease, the Consequence of Neural Cell Death. Choi SB; Kwon S; Kim JH; Ahn NH; Lee JH; Yang SH Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511515 [TBL] [Abstract][Full Text] [Related]
24. Targeting the Pathological Hallmarks of Alzheimer's Disease Through Nanovesicleaided Drug Delivery Approach. Roy R; Bhattacharya P; Borah A Curr Drug Metab; 2022; 23(9):693-707. PubMed ID: 35619248 [TBL] [Abstract][Full Text] [Related]
25. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
26. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators. Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485 [TBL] [Abstract][Full Text] [Related]
27. Autophagy Balances Neuroinflammation in Alzheimer's Disease. Cheng X; Wei Y; Qian Z; Han L Cell Mol Neurobiol; 2023 May; 43(4):1537-1549. PubMed ID: 35960407 [TBL] [Abstract][Full Text] [Related]
29. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics. Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874 [TBL] [Abstract][Full Text] [Related]
30. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets. Cai Y; Liu J; Wang B; Sun M; Yang H Front Immunol; 2022; 13():856376. PubMed ID: 35558075 [TBL] [Abstract][Full Text] [Related]
31. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review. Vicente-Zurdo D; Rosales-Conrado N; León-González ME Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100 [TBL] [Abstract][Full Text] [Related]
32. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease. Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835 [TBL] [Abstract][Full Text] [Related]
33. Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment. Li S; Qu L; Wang X; Kong L Pharmacol Ther; 2022 Mar; 231():107979. PubMed ID: 34480965 [TBL] [Abstract][Full Text] [Related]
34. Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies. Alkhalifa AE; Al-Ghraiybah NF; Kaddoumi A Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339193 [TBL] [Abstract][Full Text] [Related]
35. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets. AmeliMojarad M; AmeliMojarad M CNS Neurosci Ther; 2024 Jul; 30(7):e14856. PubMed ID: 39031970 [TBL] [Abstract][Full Text] [Related]
36. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
37. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease. Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S Front Immunol; 2020; 11():456. PubMed ID: 32296418 [TBL] [Abstract][Full Text] [Related]
39. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
40. Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms. Iliyasu MO; Musa SA; Oladele SB; Iliya AI Front Neurosci; 2023; 17():1081938. PubMed ID: 37113145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]